Zobrazeno 1 - 10
of 38
pro vyhledávání: '"C. F. Bryan"'
Publikováno v:
Animal Blood Groups and Biochemical Genetics. 8:197-207
Summary Lymphocytes from 103 Holstein cattle were tested with 11 antilymphocytotoxic sera. Four of these sera were produced by whole blood immunization; these generally yielded lymphocytotoxicity against a large number of animals in each test panel.
Autor:
C. F. Bryan, D. A. Distant, Carlton J. Young, Y. Cheng, Pang-Yen Fan, Winfred W. Williams, W. S. Cherikh
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15(12)
In 2002, the Organ Procurement and Transplantation Network (OPTN) Minority Affairs Committee (MAC) implemented a national, prospective, "variance of practice" to allow deceased donor, ABO blood group incompatible, A2 antigen, kidney transplantation i
Autor:
Rainer Blasczyk, B. J. O'brien, H.-A. Elsner, C. F. Bryan, M. Lau, G. E. Pierce, J.A. Meyer, Paul I. Terasaki, D.A. Diederich
Publikováno v:
Tissue Antigens. 56:180-183
We have defined the new allele HLA-B*4012, which had been isolated from a black individual. It was initially recognized as a serologically unique allele when typing her father for renal transplantation. The HLA class I phenotype was A*0201,*6602; B*4
Autor:
K A, Baier, L E, Markham, S P, Flaigle, P W, Nelson, C F, Shield, N A, Muruve, M I, Aeder, D, Murillo, C F, Bryan
Publikováno v:
Clinical transplantation. 17
Our organ procurement organization (OPO) evaluated the clinical and financial efficacy of point-of-care testing (POCT) in management of our deceased organ donors.Before we implemented point-of care testing with the i-STAT into routine clinical donor
Publikováno v:
Clinical transplantation. 15
In view of the influence of donor factors such as age on graft outcome and the performance standards that measure OPO productivity by the number of organs recovered and transplanted, it is important to understand the relationship of certain donor fac
Autor:
C F, Bryan, J, Martinez, N, Muruve, P W, Nelson, G E, Pierce, G, Ross, C F, Shield, B A, Warady, M I, Aeder, K M, Harrell, T S, Helling, A M, Luger
Publikováno v:
Clinical transplantation. 15
A positive crossmatch that is rendered negative by treating the serum with the IgM-reducing agent dithiothreitol (DTT) is generally reported not to influence short-term renal graft outcome. Its effect on long-term (or = 3 years) cadaveric and live-do
Publikováno v:
Annals of the New York Academy of Sciences. 677:404-406
Autor:
C F, Bryan, A M, Luger, J, Martinez, N, Muruve, P W, Nelson, G E, Pierce, G, Ross, C F, Shield, B A, Warady, M I, Aeder, T S, Helling
Publikováno v:
Transplantation. 71(7)
Cadaveric kidneys experiencing longer cold ischemia time (CIT) are associated with higher levels of delayed graft function, acute rejection, and early graft loss. One mechanism to explain these results is that ischemia/reperfusion (I/R) injury makes
Autor:
H A, Elsner, B J, O'Brien, C F, Bryan, J A, Meyer, D A, Diederich, G E, Pierce, M, Lau, P I, Terasaki, R, Blasczyk
Publikováno v:
Tissue antigens. 56(2)
We have defined the new allele HLA-B*4012, which had been isolated from a black individual. It was initially recognized as a serologically unique allele when typing her father for renal transplantation. The HLA class I phenotype was A*0201,*6602; B*4
Autor:
C F, Bryan, C F, Shield, G E, Pierce, B A, Warady, M I, Aeder, J, Martinez, A M, Luger, P W, Nelson, G, Ross, N, Muruve, S I, Mitchell
Publikováno v:
Clinical transplantation. 14(1)
The purpose of our investigation was to evaluate long-term graft survival and the role of histocompatibility in patients who were highly sensitized to human leukocyte antigen (HLA) Class I antigens and received a cadaveric renal transplant. Our multi